Rad AI’s Post

🌟 Meet Our Stellar Fellow at Acer Medical!🌟 Hank Tsai 蔡金翰(RD Senior Manager) Reason for Joining Acer Medical: I am deeply interested in the application of AI technology in the field of healthcare and hope to be a part of it, witnessing how this technology can benefit humanity. Job Responsibilities: As the head of both the Research and Development (R&D) department and the Manufacturing department, I lead the RD team in developing AI medical equipment and obtaining certifications, while ensuring the production of high-quality products. Perspectives on AI Application in Healthcare: The Issues of Insufficient Healthcare Resources and Inequality in Public Health have persisted, and AI technology is poised to be the perfect solution to these problems. AI can provide continuous, highly accurate, and consistent results (without fatigue and with consistent standards), and it can also address the issue of insufficient medical personnel. I hope that in the near future, the cutting-edge medical technology that was once only seen in science fiction movies can become a reality. Interests: I am passionate about researching new technologies, listening to music, watching movies, and reading novels. Life Motto: Staying positive and embracing challenges. #MeetOurStellarFellowatAcerMedical

This year, I have noticed an increase in demand for experienced professionals in the medical imaging space in Europe. Here's why the spotlight is on medical imaging: - Technological Advancements: Integration of AI and machine learning into imaging systems is transforming diagnostics. - Healthcare Needs: Aging population and increasing chronic diseases rates create opportunities for radiologists and imaging technologists. - Expansion of Modalities: Rise of portable imaging solutions and advancements in imaging modalities drive demand for specialized engineers. - Regulatory Challenges: EU regulations increase the need for regulatory affairs specialists. - Digital Health Integration: Cloud-based imaging create roles for IT professionals. - Facility Expansion: Growing need for radiographers, imaging technologists, and commercial managers. - Patient-Centric Innovations: Advancing imaging technologies have resulted in a demand for professionals focused on patient support. - Research and Development: Ongoing R&D in imaging technologies opens opportunities for scientists and engineers. If you're in the medical imaging field or considering a career, reach out to have a confidential chat! #MedicalImaging #medicaldevices #AI #ImagingTechnology #DigitalHealth #Europe

The medical industry stands at a precipice. Staffing shortages and skyrocketing costs strain your ability to provide the patient care that drives you. Yet, amidst the challenges, a glimmer of hope emerges. AI is on the cusp of transforming healthcare – streamlining diagnostics, enhancing outcomes. But to fully tap into its potential, you need the right partners in medical imaging solutions. That's where INFINITT steps in. We'll guide you in integrating cutting-edge technology, overcoming hurdles, and refocusing on the heart of your mission – your patients. The time to build a future where technology and compassion intertwine is now. Let's shape it together. #HealthcareInnovation #MedicalImaging #AIinHealthcare At INFINITT, we're building, but with a belief that balanced growth is the bedrock of success. While rapid expansion may bring short-term gains, it risks straining resources and compromising the quality that defines us. By growing sustainably, we invest in innovation while preserving our core identity. This balanced approach ensures that as we scale, our commitment to high-quality products and exceptional customer experiences remains unwavering. Our mission stays true – to support YOU, our customers, and the patients who depend on you. For INFINITT, sustainable growth paves the path to long-term success, staying true to our founding principles. Let's build that future, together. www.infinittna.com

𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞: 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐆𝐮𝐢𝐝𝐞: https://lnkd.in/dSSGRqQb Medical Image Analysis Software Market to reach USD 6.46 billion by 2032 and grow at a CAGR of 7.9% over the forecast period 2024-2032. This growth can be attributed to the increasing demand for advanced medical imaging technologies, rising prevalence of chronic diseases, and the growing adoption of artificial intelligence in healthcare. The development of innovative software solutions that offer improved accuracy, efficiency, and automation in medical image analysis is also expected to drive market growth. Additionally, the integration of cloud-based platforms and machine learning algorithms is anticipated to further propel the market expansion in the coming years. Overall, the medical image analysis software market is poised for significant growth and technological advancements in the near future. Major Players Profiled in Report: GE HealthCare Siemens Healthineers Philips Healthcare Canon Medical Systems Corporation AGFA HealthCare IBM Watson Health Merge Healthcare (an IBM Company) Carestream Health TeraRecon, Inc. MIM Software Inc. AQUILAB by Coexya ContextVision AB Toshiba America Medical Systems Intrasense Esaote SpA #MedicalImageAnalysis #GEHealthcare #SiemensHealthineers #PhilipsHealthcare #CanonMedicalSystems #AgfaHealthCare #IBMWatsonHealth #MergeHealthcare #CarestreamHealth #TeraRecon #MIMSoftware #Aquilab #ContextVision #ToshibaMedicalSystems #Intrasense #EsaoteSpA #MedicalImaging #HealthcareTechnology #ImageAnalysisSoftware #RadiologyTech

𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐏𝐃𝐅 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 @ https://lnkd.in/da7ySZ5a The medical image analysis software market, valued at USD 3 billion in 2022, is projected to reach USD 5.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030. The medical image analysis software market is experiencing rapid growth due to advancements in technology and an increasing need for more accurate and efficient diagnostic tools in healthcare. This software allows for the interpretation of medical images, such as X-rays, MRIs, and CT scans, through algorithms and artificial intelligence, enabling healthcare professionals to make quicker and more accurate diagnoses. Factors driving the market growth include a rising prevalence of chronic diseases, a growing aging population worldwide, and an increasing demand for advanced imaging technologies. Additionally, the integration of cloud-based solutions and machine learning techniques in medical image analysis software is further propelling market expansion. Key players in this industry are constantly innovating to provide better solutions that enhance clinical outcomes and improve patient care. Overall, the global medical image analysis software market is poised for continuous growth as technology continues to evolve in the healthcare sector. 𝐓𝐡𝐞 𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 → Esaote,  → AQUILAB by Coexya .,  → GE HealthCare, → Koninklijke Philips N.V., → MIM Software, → Spacelabs Healthcare, → MERGE HEALTHCARE LTD, → Siemens Healthineers, → Toshiba America Medical Systems ,  → and other players. #MedicalImageAnalysis #HealthTech #MedicalSoftware #ImagingTechnology #HealthcareInnovation #Radiology #MedicalDiagnostics #MarketGrowth #HealthcareIT #MedicalImaging #ClinicalResearch #CAGR #DigitalHealth #AIinHealthcare #MedicalTechnology

🔬💡 Why you should invest in your R&D Team (Med Tech) 🔬💡 In today's rapidly evolving Medical Device landscape, innovation is the key to addressing unmet medical needs, improving patient outcomes, and driving advancements in treatment modalities. Research and Development (R&D) serves as the lifeblood of the med tech industry, propelling us forward into a future where healthcare is more personalized, precise, and accessible than ever before. Here are a few reasons why R&D is crucial in Med Tech: 1️⃣ Innovation: R&D fuels innovation by pushing the boundaries of what's possible in medical technology. From breakthrough treatments to cutting-edge devices, each advancement opens up new avenues for improving patient care and quality of life. 2️⃣ Addressing Unmet Needs: By investing in R&D, we can address unmet medical needs and tackle some of the most pressing challenges in healthcare. Whether it's developing novel therapies for rare diseases or designing innovative solutions for chronic conditions, R&D plays a pivotal role in driving progress. 3️⃣ Staying Ahead of the Curve: In a competitive market, staying ahead of the curve is essential. Investing in R&D allows companies to stay agile, anticipate future trends, and maintain a competitive edge in an ever-evolving landscape. As we look to the future of healthcare, let's continue to prioritise and invest in R&D in Med Tech. Together, we can harness the power of innovation to transform the way we prevent, diagnose, and treat disease, ultimately improving lives and shaping a healthier world. If you are looking to grow you R&D Team then let's talk! 💪🏥 #MedTech #Innovation #ResearchAndDevelopment #HealthcareInnovation #engineeringrecruitment

Hey, Fractional Execs.... Promoting your skills like a surgeon rather than a general practice doctor will likely result in more opportunities. You might look like the other thousands of GTM, CRO, CMO, CTO, CPO, and CFOs who wave the same fractional banners. We are accelerating Fractionals to pivot to be a "Surgeon with AI." Let's help you pivot and secure advisory work faster.

🚀 Navigating the Digital Wave in Medical Device Sales: What's Next? 🚀 In the medical device industry, the incorporation of digital health technologies represents a revolution rather than a fad. Success as a sales professional depends on your ability to comprehend and adjust to this shift. Let's examine the main advancements: AI and machine learning:  There are a plethora of sales prospects available due to AI's expanding role in healthcare, which includes personalised treatment plans and predictive diagnostics. Presenting compelling value propositions will be made possible by your understanding of how AI-driven devices assist healthcare practitioners. Digital Biomarkers and Remote Monitoring:  The growing acceptance of remote data collecting and the emergence of digital biomarkers have forced sales strategies to change to focus more on data-driven healthcare solutions and remote patient monitoring. Regulatory Landscape: The regulatory landscape is complex and requires careful navigation, particularly in light of the recent modifications brought about by COVID-19. Sales professionals must remain up to date on regulatory compliance and how it affects product development and market entry tactics. Market Expansion and Global Reach:  Digital health technologies are expanding the global reach of medical devices. Understanding market-specific needs and regulatory differences is key to successful international sales strategies. The future is here, and it's digital Are there any considerations that I have missed? Let me know your thoughts below!  #DigitalHealth #MedicalDeviceSales #Innovation"

Driven by Passion, Self-Funded Companies Can Craft Their Own Destinies! A 2023 thank you note to ScImage teams, customers, friends, and partners. When the number and frequency of deployments test the capacity of your resources, what do you do? You put your head down, talk less, do more, and get it done, one task at a time, and make customers happy one at a time. That has been the most satisfying experience this year. Now, I see the challenge in fine-tuning individual multispecialty workflows the way they like, as compared to the conveyor belt mentality in radiology workflows. Looking back, we did the opposite of everything they teach in business schools about building companies that look successful mostly in financials. We hired people for who they are and certainly not just to fill positions. In good times, we shared rewards, and in bad times, we pumped more personal dollars and worked towards better times. We flattened the organization and promoted open sharing of ideas, roadblocks, pain points and solutions. Most importantly, we placed our customers at the center of the business and respected their likes and dislikes. We made machines work hard to make humans' lives easy. The new hyped-up word for that is AI automation, but the physician, tech, and patient combination doesn’t care what you call it when their needs are met. We thank all our customers for believing in us. We thank all our friends and business partners. And I thank everyone at ScImage for their positive energy that is truly contagious. Life in clinical workflow trenches is pleasantly beautiful. #ScImage #CloudPACS #Cardiology #multispeciality #PICOM365

We're excited to exclusively present a compelling opportunity to invest in a highly scalable comprehensive AI solution for medical imaging, represented by PRIME exits and American HealthCare Capital. This innovative company offers artificial intelligence software designed to streamline imaging diagnosis and reporting for healthcare providers. Their cutting-edge solution enhances precision in billing procedures, enabling practices to expand patient volume without increasing staff. By automating workflows, the AI technology boosts efficiency, allowing radiology groups to scale operations and raise productivity without compromising quality or accuracy. The Problem: - Excessive time spent generating imaging reports. - Slow diagnosis and delayed treatment due to soiled imaging data. - Misinterpretation risks leading to patient and provider jeopardy. - Operational inefficiencies inflate overhead costs. The Solution: - The company's cloud platform leverages AI to deliver imaging analysis software on demand. - This SaaS offering swiftly generates precise imaging reports, boosting diagnostic productivity. - Optimized workflows lower operating costs and time spent on report creation. - Seamless sharing and collaboration of imaging information enhance patient care. Sales Pipeline Traction and Financials: - Secured $1.55 million in funding, launched in 300+ healthcare facilities, and signed up 50 paying customers. - Generated $1.3 million in revenue in 2023 and $1.9 million in Q1 2024, with projected recurring revenue of $3 million in 2024. - Expects profitability in Q3 2024 and forecasts $6-7 million in annual recurring revenue by end of 2025. The Ask: - Seeking a strategic partner to aggressively market and scale the solution. - Open to various deal structures, including equity exchange or selling a majority stake. - Asking price to be determined. For further details and to explore this exciting venture, please contact Ms. Palak Jain at Palak@pexits.com or Dr. Allen Nazeri DDS MBA at Allen@ahcteam.com. #MedicalImaging #AIinHealthcare #HealthTech #Radiology #ArtificialIntelligence #HealthcareInnovation #DiagnosticImaging #HealthcareAI #DigitalHealth #MedicalTechnology #HealthcareTech #ImagingSoftware #PatientCare #HealthcareIT #HealthcareAnalytics #TechInMedicine #InnovativeHealthcare #PRIMEExits #AmericanHealthcareCapital #InvestmentOpportunity #PrivateEquity #InstitutionalInvestors #HealthcareInvestment